KRISTEN DIRKS-FINLEY
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner RENO, NV NPI 1609547488
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner NV Novo Nordisk AS All categories
General Payments — all program years on this page
$160.15
- Category: General Payments
- Program years: PY2022
- Record count: 9
- As of (CMS publication): 2026-01-23
Latest program year (PY2022): $160.15 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2022) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $160.15 | 9 |
By paying entity
Latest program year (PY2022) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $108.25 | 6 |
| Amgen Inc. | $20.20 | 1 |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | $17.21 | 1 |
| ABBVIE INC. | $14.49 | 1 |
By program year
| Program year | Amount | Records |
|---|---|---|
| 2022 | $160.15 | 9 |
Records — PY2022 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 891796555 | ABBVIE INC. | $14.49 | 02/24/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 898601145 | Novo Nordisk Inc | $12.89 | 04/07/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 899121367 | Novo Nordisk Inc | $21.42 | 05/04/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 899174057 | Novo Nordisk Inc | $14.15 | 02/11/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 899174065 | Novo Nordisk Inc | $15.25 | 03/23/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 899218792 | Novo Nordisk Inc | $30.84 | 03/17/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 899279193 | Novo Nordisk Inc | $13.70 | 06/17/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 923822789 | Biohaven Pharmaceutical Holding Company Ltd. | $17.21 | 03/10/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 939541861 | Amgen Inc. | $20.20 | 06/09/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.